Abstract
Background The combustion of solid fuels (e.g., wood, coal, and charcoal) for cooking fuel is widespread in low– and middle-income countries. The use of these fuels increases exposure to airborne pollutants which have been shown to increase the risk of disease and premature death, particularly among older individuals. Despite this, most studies examining this association come from India and China. Furthermore, few studies have examined this association among the elderly. This study aims to fill this gap by examining the association between household cooking fuel and chronic respiratory disease.
Methods We analyzed data from Wave 2 of the World Health Organization’s Study on Global Ageing and Adult Health. Our study sample consists of 7,253 adults aged 50+ from Mexico and Ghana. Logistic regression was conducted to study the association between chronic respiratory disease (measured by whether the participant reported having either (1) a medical diagnosis for chronic obstructive pulmonary disorder, chronic bronchitis, or emphysema, or (2) symptoms suggesting chronic lung infection), and the main cooking fuel used by the household.
Results The prevalence of chronic respiratory disease was 6.55% and 17.45% for Ghana and Mexico, respectively. 15.96%, and 22.47% of participants lived in households using solid fuels for cooking. Adjusting for covariates, solid fuel use was associated with 1.72 (95%CI: 1.07-2.79; p=0.026) times higher odds of chronic respiratory disease. Regional disparities were found, with individuals in Mexico and Ghana respectively having 1.70 (95%CI:1.01-2.89; p=0.049) and 3.40 (95%CI:1.50-7.72; p=0.004) higher adjusted odds for chronic respiratory disease.
Conclusions Our results confirm the association found between the use of solid fuels and increased chronic respiratory disease risk. These findings demonstrate the salience of improving access to clean cooking fuels and methods, especially for households in the sub-Saharan region, particularly, women. Policy interventions need to capture the unique needs of women to ensure that health outcomes from energy use are well-mitigated.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The research reported in this publication was supported by the Canada Research Chairs Program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Canada Research Chair Program.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data from SAGE Ghana wave 2 and SAGE Mexico wave 2 were used for this study. WHO Ethics Review Committee (reference number RPC149) with local approval from the University of Ghana Medical School Ethics and Protocol Review Committee. The Ethics and Research Committees of the National Institute of Public Health in Mexico approved the Mexico SAGE data. All participants were provided with a detailed explanation of study procedures and signed an informed consent letter. The necessary permission was obtained from the World Health Organization to use these data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data from SAGE Ghana Wave 2 & SAGE Mexico Wave 2 were used for this study. WHO SAGE was approved by the WHO Ethics Review Committee (reference number RPC149) with local approval from the University of Ghana Medical School Ethics and Protocol Review Committee (Ghana). The Ethics and Research Committees of the National Institute of Public health in Mexico approved the SAGE Mexico Study. All files were obtained from the World Health Organization Study on global AGEing and adult health (WHO SAGE). Details on data can be found at http://www.who.int/healthinfo/sage/cohorts/en/. The authors used files GhanaINDDataW2, GhanaHHDataW2, MexicoINDDataW2, and MexicoHHDataW2. The authors confirm that they had no special access privileges to the data. Interested researchers can apply to WHO to access data (http://apps.who.int/healthinfo/systems/surveydata/index.php/catalog/sage/about).
